NASDAQ: ALLO

ALLO’s price-to-book ratio: An indicator of the company’s performance
Kenneth Phillips
Allogene Therapeutics Inc (ALLO)’s stock is trading at $1.32 at the moment marking a rise of 4.37% from the last ...

Allogene Therapeutics Inc (ALLO)’s stock is trading at $1.32 at the moment marking a rise of 4.37% from the last ...